ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 747271 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 747271; 2) Community: the network communities that were significantly associated with the response to NSC 747271; 3) Molecule: the relationships between components within communities and NSC 747271; 4) MDR: the compounds that were significantly associated with the NSC 747271.

NSC Compound Enrichment Correlation
NSC 730214 N6-(2-methoxyphenyl)-5-methyl-4-oxo-3-(2-phenoxyethyl)-3,4-d ihydrothieno[2,3-d]pyrimidine-6-carboxamide 0.0454469012959173 0.052972597
NSC 736606 Null 0.0454469012959173 0.018156906
NSC 737225 Null 0.0454469012959173 0.24793701
NSC 740846 6-(3-fluoro-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2H-pyran-2-one 0.0454469012959173 0.19660056
NSC 743506 N-(benzo[d]thiazol-2-yl)-2-(4-((3-oxobenzofuran-2(3H)-ylidene)methyl)phenoxy)acetamide 0.0454469012959173 0.24909751
NSC 743853 Null 0.0454469012959173 0.27727877
NSC 746701 N-(4-Chlorophenyl)-N-({[2-(4-chlorophenyl)ethyl]amino]carbonothioyl)benzamide 0.0454469012959173 0.31042416
NSC 142475 Null 0.0459335986102865 0.18120282
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0459335986102865 -0.15129445
NSC 180973 Tamoxifen citrate 0.0459335986102865 0.43559726
Total:62  Current:55    [First] [Prev] [Next] [Last]